<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">  <id>4b61c590-fbcf-42c0-9ed5-ef18b6b53365</id>  <name>VTE Prophylaxis_Hip and Knee Arthroplasty Adult Order Panel</name>  <description>    <lifecycle_state>Initial</lifecycle_state>    <details>      <purpose/>      <use/>      <misuse/>    </details>    <other_details>      <item>        <key>MetaDataSet:Sample Set </key>        <value>Template metadata sample set </value>      </item>      <item>        <key>Acknowledgements</key>        <value/>      </item>      <item>        <key>Business Process Level</key>        <value/>      </item>      <item>        <key>Care setting</key>        <value/>      </item>      <item>        <key>Client group</key>        <value/>      </item>      <item>        <key>Clinical Record Element</key>        <value/>      </item>      <item>        <key>Copyright</key>        <value/>      </item>      <item>        <key>Issues</key>        <value/>      </item>      <item>        <key>Owner</key>        <value/>      </item>      <item>        <key>Sign off</key>        <value/>      </item>      <item>        <key>Speciality</key>        <value/>      </item>      <item>        <key>User roles</key>        <value/>      </item>    </other_details>  </description>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">    <items>      <item>        <key>Technical.ï»© Technical Traceability</key>        <value>{~AHSID~4b61c590-fbcf-42c0-9ed5-ef18b6b53365~NAME~VTE Prophylaxis_Hip and Knee Arthroplasty Adult Order Panel}</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;table&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;u&gt;&lt;strong&gt;- Caprini Score&lt;/strong&gt;&lt;/u&gt; (URL: https://www.thecalculator.co/health/Caprini-Score-For-DVT-Calculator-1108.html)&lt;/td&gt;&lt;td&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;Total duration of prophylaxis: 14 days for Knee Arthroplasty; 35 days for Hip Arthroplasty&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Contraindication to Anticoagulation&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;&amp;nbsp;For any patients with contraindications to pharmacologic VTE prophylaxis.&amp;nbsp;&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;rivaroxaban and acetylsalicylic acid - Hip&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;rivaroxaban tablet; 10 mg, oral, every 24 hours, First dose tomorrow at 0800, For 5 days&apos;]/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Restricted drug: Prevention of stroke and systemic embolism&lt;/p&gt;</value>      </item>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting S+1 @ 0800&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;rivaroxaban and acetylsalicylic acid - Hip&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;rivaroxaban tablet; 10 mg, oral, every 24 hours, First dose tomorrow at 0800, For 5 days&apos;]/activities[at0156]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;rivaroxaban and acetylsalicylic acid - Hip&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;acetylsalicylic acid tablet enteric-coated; 81 mg, oral, daily, For 30 days&apos;]/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Acetylsalicylic acid (ASA) to be given for 30 days for Hip Arthroplasty.&lt;br&gt;Start day after last dose of rivaroxaban given.&lt;/p&gt;</value>      </item>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting S+6 @ 0800&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;rivaroxaban and acetylsalicylic acid - Hip&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;acetylsalicylic acid tablet enteric-coated; 81 mg, oral, daily, For 30 days&apos;]/activities[at0156]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin and acetylsalicylic acid - Hip&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;Select BOTH tinzaparin orders and the ASA order.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin and acetylsalicylic acid - Hip&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;&lt;br&gt;&amp;nbsp;&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin and acetylsalicylic acid - Hip&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;Please close this order and enter a weight on this patient so that the correct dosage will populate. &amp;nbsp;Alternatively, use the dosing chart to determine the appropriate dose.&lt;br&gt;&amp;nbsp;&lt;/p&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width:0px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:133px&quot;&gt;&lt;p&gt;&lt;strong&gt;Weight Band&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patient Actual Body Weight&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top; width:258px&quot;&gt;&lt;p&gt;&lt;strong&gt;Tinzaparin Dose (units)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:133px&quot;&gt;&lt;p&gt;Less than 30 kg&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top; width:258px&quot;&gt;&lt;p&gt;2500 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:133px&quot;&gt;&lt;p&gt;30 to 39.9 kg&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top; width:258px&quot;&gt;&lt;p&gt;3500 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:133px&quot;&gt;&lt;p&gt;40 to 100 kg&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top; width:258px&quot;&gt;&lt;p&gt;4500 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:133px&quot;&gt;&lt;p&gt;100.1 to 120 kg&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top; width:258px&quot;&gt;&lt;p&gt;8000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:133px&quot;&gt;&lt;p&gt;120.1 kg to 150 kg&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top; width:258px&quot;&gt;&lt;p&gt;10,000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:133px&quot;&gt;&lt;p&gt;150.1 to 175 kg&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top; width:258px&quot;&gt;&lt;p&gt;12,000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:133px&quot;&gt;&lt;p&gt;175.1 to 200 kg&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top; width:258px&quot;&gt;&lt;p&gt;14,000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:133px&quot;&gt;&lt;p&gt;200.1 to 250 kg&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top; width:258px&quot;&gt;&lt;p&gt;16,000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:133px&quot;&gt;&lt;p&gt;Greater than 250 kg&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top; width:258px&quot;&gt;&lt;p&gt;75 units/kg SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin and acetylsalicylic acid - Hip&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Do not start q24h dose LESS than 12 hours after previous tinzaparin dose.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin and acetylsalicylic acid - Hip&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0156]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin and acetylsalicylic acid - Hip&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin and acetylsalicylic acid - Hip&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin and acetylsalicylic acid - Hip&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting S+8 @ 0800&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Acetylsalicylic acid to be given for 28 days for Hip Arthroplasty&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin and acetylsalicylic acid - Hip&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0156]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;rivaroxaban and acetylsalicylic acid - Knee&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;rivaroxaban tablet; 10 mg, oral, every 24 hours, First dose tomorrow at 0800, For 5 days&apos;]/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Restricted drug: Prevention of stroke and systemic embolism&lt;/p&gt;</value>      </item>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting S+1 @ 0800&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;rivaroxaban and acetylsalicylic acid - Knee&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;rivaroxaban tablet; 10 mg, oral, every 24 hours, First dose tomorrow at 0800, For 5 days&apos;]/activities[at0156]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;rivaroxaban and acetylsalicylic acid - Knee&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;acetylsalicylic acid tablet enteric-coated; 81 mg, oral, daily, For 9 days&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Start on S+6 @ 0800&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Acetylsalicylic acid (ASA) to be given for 9 days for Knee Arthroplasty.&lt;br&gt;Start day after last dose of rivaroxaban given.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;rivaroxaban and acetylsalicylic acid - Knee&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;acetylsalicylic acid tablet enteric-coated; 81 mg, oral, daily, For 9 days&apos;]/activities[at0156]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin and acetylsalicylic acid - Knee&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;Select BOTH tinzaparin orders and the ASA order.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin and acetylsalicylic acid - Knee&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;Please close this order and enter a weight on this patient so that the correct dosage will populate. &amp;nbsp;Alternatively, use the dosing chart to determine the appropriate dose.&lt;br&gt;&amp;nbsp;&lt;/p&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&lt;strong&gt;Weight Band&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patient Actual Body Weight&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;&lt;strong&gt;Tinzaparin Dose (units)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Less than 30 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;2500 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;30 to 39.9 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;3500 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;40 to 100 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;4500 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;100.1 to 120 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;8000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;120.1 kg to 150 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;10,000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;150.1 to 175 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;12,000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;175.1 to 200 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;14,000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;200.1 to 250 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;16,000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Greater than 250 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;75 units/kg SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin and acetylsalicylic acid - Knee&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Do not start q24h dose LESS than 12 hours after previous tinzaparin dose.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin and acetylsalicylic acid - Knee&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0156]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin and acetylsalicylic acid - Knee&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin and acetylsalicylic acid - Knee&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin and acetylsalicylic acid - Knee&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Acetylsalicylic acid (ASA) to be given for 7&amp;nbsp;days for Knee Arthroplasty.&lt;/p&gt;</value>      </item>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting S+8 @ 0800&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;High Risk with NO additional VTE factors&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;tinzaparin and acetylsalicylic acid - Knee&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0156]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;Treat with rivaroxaban, apixaban, or low molecular weight heparin for full course (14 days for knee arthroplasty; 35 days for hip arthroplasty) in patients with prior VTE or thrombophilia/active cancer or on hormone therapy.&amp;nbsp;&lt;br&gt;SELECT one option from Day of Surgery section &lt;strong&gt;AND&lt;/strong&gt; one option from Post Operative Day 1 section.&amp;nbsp;&lt;br&gt;&amp;nbsp;&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Day of Surgery - Hip Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Day of Surgery - Hip Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;tinzaparin injection; 2,500 units, subcutaneous, once, Give 12 hours Post-Op&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting H+12 hours&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Day of Surgery - Hip Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;heparin injection for bolus - units, units/kg/dose; 5,000 units, subcutaneous, once, Give 12 hours Post-Op. Consider in patients with Creatinine Clearance LESS than 20 mL/min.&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting H+12 hours&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Day of Surgery - Hip Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;apixaban tablet; 2.5 mg, oral, once, Start 12 hours post op. Consider in patients with higher risk of bleeding&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting H+12 hours&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Restricted drug: Prevention of venous thromboembolic events in patient who has undergone elective knee or hip replacement surgery&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Day of Surgery - Hip Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;rivaroxaban tablet; 10 mg, oral, once; Start 12 hours post-op&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting H+12 hours&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Restricted drug: Prevention of stroke and systemic embolism&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;Please close this order and enter a weight on this patient so that the correct dosage will populate. &amp;nbsp;Alternatively, use the dosing chart to determine the appropriate dose.&lt;br&gt;&amp;nbsp;&lt;/p&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&lt;strong&gt;Weight Band&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patient Actual Body Weight&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;&lt;strong&gt;Tinzaparin Dose (units)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Less than 30 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;2500 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;30 to 39.9 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;3500 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;40 to 100 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;4500 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;100.1 to 120 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;8000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;120.1 kg to 150 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;10,000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;150.1 to 175 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;12,000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;175.1 to 200 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;14,000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;200.1 to 250 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;16,000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Greater than 250 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;75 units/kg SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;If required adjust initial q24h dose to ensure at least 12 hours after initial postoperative tinzaparin dose&amp;nbsp;&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0156]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;N&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Hip Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;rivaroxaban tablet; 10 mg, oral, every 24 hours, for 35 days&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Start S+1&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Start Post Op Day 1 for 35 days.&amp;nbsp;&lt;br&gt;&amp;nbsp;If tinzaparin given day of surgery, adjust initial rivaroxaban dose to ensure at least 12 hours after initial postoperative tinzaparin dose&amp;nbsp;&lt;/p&gt;&lt;p&gt;Restricted drug: Prevention of stroke and systemic embolism&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Hip Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;apixaban tablet; 2.5 mg, oral, every 12 hours, For 35 days&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Start S+1 @ 0800&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Start Post Op Day 1 for 35 days.&amp;nbsp;&lt;br&gt;If tinzaparin given day of surgery, adjust initial apixaban dose to ensure at least 12 hours after initial postoperative tinzaparin dose&amp;nbsp;&lt;/p&gt;&lt;p&gt;Restricted drug: Prevention of venous thromboembolic events in patient who has undergone elective knee or hip replacement surgery&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Hip Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;heparin injection for bolus - units, units/kg/dose; 5,000 units, subcutaneous, every 12 hours, For 35 days&apos;]/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Start Post Op Day 1.&amp;nbsp;&lt;br&gt;If required adjust initial q12h dose to ensure at least 12 hours after initial postoperative heparin dose.&lt;br&gt;Extended therapy for 35 days.&lt;/p&gt;</value>      </item>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Start S+1 @ 0800&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Hip Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Hip Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;N&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Day of Surgery - Knee Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;tinzaparin injection; 2,500 units, subcutaneous, once, Give 12 hours Post-Op&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting H+12 hours&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Day of Surgery - Knee Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;heparin injection for bolus - units, units/kg/dose; 5,000 units, subcutaneous, once, Give 12 hours Post-Op. Consider in patients with Creatinine Clearance LESS than 20 mL/min.&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting H+12 hours&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Day of Surgery - Knee Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;apixaban tablet; 2.5 mg, oral, once&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting H+12 hours&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Start 12 hours post op.&lt;br&gt;Consider in patients with higher risk of bleeding.&lt;br&gt;Restricted drug: Prevention of venous thromboembolic events in patient who has undergone elective knee or hip replacement surgery&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Day of Surgery - Knee Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;rivaroxaban tablet; 10 mg, oral, once&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting H+12 hours&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Start 12 hours post op&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Day of Surgery - Knee Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;Please close this order and enter a weight on this patient so that the correct dosage will populate. &amp;nbsp;Alternatively, use the dosing chart to determine the appropriate dose.&lt;br&gt;&amp;nbsp;&lt;/p&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&lt;strong&gt;Weight Band&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patient Actual Body Weight&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;&lt;strong&gt;Tinzaparin Dose (units)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Less than 30 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;2500 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;30 to 39.9 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;3500 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;40 to 100 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;4500 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;100.1 to 120 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;8000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;120.1 kg to 150 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;10,000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;150.1 to 175 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;12,000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;175.1 to 200 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;14,000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;200.1 to 250 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;16,000 units SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Greater than 250 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;75 units/kg SUBCUTANEOUSLY once daily&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting S+1 @ 0800&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;If required adjust initial q24h dose to ensure at least 12 hours after initial postoperative tinzaparin dose&amp;nbsp;&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0156]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;N&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Knee Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;rivaroxaban tablet; 10 mg, oral, every 24 hours, for 14 days&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting S+1&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Start Post Op Day 1 for 14 days.&amp;nbsp;&lt;br&gt;If tinzaparin given day of surgery, adjust initial rivaroxaban dose to ensure at least 12 hours after initial postoperative tinzaparin dose&amp;nbsp;&lt;/p&gt;&lt;p&gt;Restricted drug: Prevention of stroke and systemic embolism&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Knee Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;apixaban tablet; (Consider in patients with higher risk of bleeding); 2.5 mg, oral, every 12 hours, starting tomorrow for 14 days&apos;]/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Start Post Op Day 1 for 14 days.&amp;nbsp;&lt;br&gt;If tinzaparin given day of surgery, adjust initial apixaban dose to ensure at least 12 hours after initial postoperative tinzaparin dose&amp;nbsp;&lt;/p&gt;&lt;p&gt;Restricted drug: Prevention of venous thromboembolic events in patient who has undergone elective knee or hip replacement surgery&lt;/p&gt;</value>      </item>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting S+1 @ 0800&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Knee Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;heparin injection for bolus - units, units/kg/dose; 5,000 units, subcutaneous, every 12 hours, For 14 days&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting S+1 @ 0800&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Start Post Op Day 1.&amp;nbsp;&lt;br&gt;If required adjust initial q12h dose to ensure at least 12 hours after initial postoperative heparin dose.&lt;br&gt;Extended therapy for 14&amp;nbsp;days.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Knee Arthroplasty&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Post Operative Day 1 - Knee Arthroplasty&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Long-term Anticoagulation Resumption&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;warfarin tablet; *** mg, oral, once, tomorrow&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting S+1&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Adjust dose as per dialy order. Ensure patient has a daily INR order starting POD 1&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Long-term Anticoagulation Resumption&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;dabigatran capsule; 110 mg, oral, every 12 hours&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting S+2&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Start Post Op Day 2.&amp;nbsp;&lt;br&gt;Discontinue prophylaxis once resumed.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Long-term Anticoagulation Resumption&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;dabigatran capsule; 150 mg, oral, every 12 hours&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting S+2&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Start Post Op Day 2.&amp;nbsp;&lt;br&gt;Discontinue prophylaxis once resumed.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Long-term Anticoagulation Resumption&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;rivaroxaban tablet; 15 mg, oral, every 24 hours&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting S+2&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Start Post Op Day 2.&amp;nbsp;&lt;br&gt;Discontinue prophylaxis once resumed.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Long-term Anticoagulation Resumption&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;rivaroxaban tablet; 20 mg, oral, every 24 hours&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting S+2&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Start Post Op Day 2.&amp;nbsp;&lt;br&gt;Discontinue prophylaxis once resumed.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Long-term Anticoagulation Resumption&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;apixaban tablet; 2.5 mg, oral, every 12 hours&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting S+2&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Start Post Op Day 2.&amp;nbsp;&lt;br&gt;Discontinue prophylaxis once resumed.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Long-term Anticoagulation Resumption&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;apixaban tablet; 5 mg, oral, every 12 hours&apos;]/activities[at0001]">    <items>      <item>        <key>Transform.Technical Notes</key>        <value>&lt;p&gt;Starting S+2&lt;/p&gt;</value>      </item>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;Start Post Op Day 2.&amp;nbsp;&lt;br&gt;Discontinue prophylaxis once resumed.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;N&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;CBC, No Differential; Every 3 days, for 5 occurrences&apos;]/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;To monitor platelet count for heparin-induced thrombocytopenia (HIT) in heparin-exposed patients with risk of HIT greater than 1%.&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;N&lt;/p&gt;</value>      </item>    </items>  </annotations>  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="VTE Prophylaxis - Hip and Knee Arthroplasty Adult">    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Treatment Options">      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Contraindication to Anticoagulation">        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="528e44bc-af74-465f-a535-3a62f4bb1d0c" concept_name="PC Sequential Compression Device Order" max="1" path="/items" name="Sequential Compression Device; Until discontinued, Apply, Remove while ambulating, For patients with a high risk of bleeding, use SCDs at least until the initial risk of bleeding decreases"/>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="df94fc61-7e8a-4890-8269-d3cea3b1064f" concept_name="PC AntiEmbolism Stockings Order" max="1" path="/items" name="AntiEmbolism Stockings; Until discontinued"/>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>      </Item>      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="High Risk with NO additional VTE factors">        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Hip Arthroplasty">          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="rivaroxaban and acetylsalicylic acid - Hip">            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="95622e40-f0c5-4230-986a-417f0e26cf42" concept_name="PHARM rivaroxaban Tablet Order" max="1" path="/items" name="rivaroxaban tablet; 10 mg, oral, every 24 hours, First dose tomorrow at 0800, For 5 days"/>            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="FOLLOWED BY"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="dcd2aac9-284c-4ca8-8df7-30d13a1bbf58" concept_name="PHARM acetylsalicylic acid Enteric-coated tablet Order" max="1" path="/items" name="acetylsalicylic acid tablet enteric-coated; 81 mg, oral, daily, For 30 days"/>          </Item>          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="tinzaparin and acetylsalicylic acid - Hip">            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="tinzaparin starting post-op day 1">              <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="VTE Prophylaxis Patient weight">                <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>                <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection; *** units, subcutaneous, every 24 hours, First dose tomorrow at 0800, For 7 days"/>                <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>              </Item>              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>            </Item>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="dcd2aac9-284c-4ca8-8df7-30d13a1bbf58" concept_name="PHARM acetylsalicylic acid Enteric-coated tablet Order" max="1" path="/items" name="acetylsalicylic acid tablet enteric-coated; 81 mg, oral, daily, For 28 days"/>          </Item>          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>        </Item>        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Knee Arthroplasty">          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="rivaroxaban and acetylsalicylic acid - Knee">            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="95622e40-f0c5-4230-986a-417f0e26cf42" concept_name="PHARM rivaroxaban Tablet Order" max="1" path="/items" name="rivaroxaban tablet; 10 mg, oral, every 24 hours, First dose tomorrow at 0800, For 5 days"/>            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="FOLLOWED BY"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="dcd2aac9-284c-4ca8-8df7-30d13a1bbf58" concept_name="PHARM acetylsalicylic acid Enteric-coated tablet Order" max="1" path="/items" name="acetylsalicylic acid tablet enteric-coated; 81 mg, oral, daily, For 9 days"/>          </Item>          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="tinzaparin and acetylsalicylic acid - Knee">            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="tinzaparin starting post-op day 1">              <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="VTE Prophylaxis Patient weight">                <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>                <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection; *** units, subcutaneous, every 24 hours, First dose tomorrow at 0800, For 7 days"/>                <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>              </Item>              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>            </Item>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="dcd2aac9-284c-4ca8-8df7-30d13a1bbf58" concept_name="PHARM acetylsalicylic acid Enteric-coated tablet Order" max="1" path="/items" name="acetylsalicylic acid tablet enteric-coated; 81 mg, oral, daily, For 7 days"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>          </Item>        </Item>      </Item>      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Very High Risk WITH additional VTE factors (ie prior VTE, thrombophilia/active cancer or on hormone therapy)">        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Hip Arthroplasty">          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Day of Surgery - Hip Arthroplasty">            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection; 2,500 units, subcutaneous, once, Give 12 hours Post-Op"/>            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f6df7262-0810-4ee2-bb10-c315c36e987c" concept_name="PHARM heparin, preservative free injection Order" max="1" path="/items" name="heparin injection for bolus - units, units/kg/dose; 5,000 units, subcutaneous, once, Give 12 hours Post-Op. Consider in patients with Creatinine Clearance LESS than 20 mL/min."/>            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="e0b7bb91-f3d1-4c1e-a84c-c2120d78b802" concept_name="PHARM apixaban Tablet Order" max="1" path="/items" name="apixaban tablet; 2.5 mg, oral, once, Start 12 hours post op. Consider in patients with higher risk of bleeding"/>            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="95622e40-f0c5-4230-986a-417f0e26cf42" concept_name="PHARM rivaroxaban Tablet Order" max="1" path="/items" name="rivaroxaban tablet; 10 mg, oral, once; Start 12 hours post-op"/>          </Item>          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Post Operative Day 1 - Hip Arthroplasty">            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="tinzaparin injection (Extended for 35 days)">              <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="VTE Prophylaxis Patient weight">                <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>                <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection; *** units, subcutaneous, every 24 hours, First dose tomorrow at 0800, For 35 days"/>                <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>              </Item>              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>            </Item>            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="95622e40-f0c5-4230-986a-417f0e26cf42" concept_name="PHARM rivaroxaban Tablet Order" max="1" path="/items" name="rivaroxaban tablet; 10 mg, oral, every 24 hours, for 35 days"/>            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="e0b7bb91-f3d1-4c1e-a84c-c2120d78b802" concept_name="PHARM apixaban Tablet Order" max="1" path="/items" name="apixaban tablet; 2.5 mg, oral, every 12 hours, For 35 days"/>            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f6df7262-0810-4ee2-bb10-c315c36e987c" concept_name="PHARM heparin, preservative free injection Order" max="1" path="/items" name="heparin injection for bolus - units, units/kg/dose; 5,000 units, subcutaneous, every 12 hours, For 35 days"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>          </Item>          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>        </Item>        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #3"/>        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Knee Arthroplasty">          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Day of Surgery - Knee Arthroplasty">            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection; 2,500 units, subcutaneous, once, Give 12 hours Post-Op"/>            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f6df7262-0810-4ee2-bb10-c315c36e987c" concept_name="PHARM heparin, preservative free injection Order" max="1" path="/items" name="heparin injection for bolus - units, units/kg/dose; 5,000 units, subcutaneous, once, Give 12 hours Post-Op. Consider in patients with Creatinine Clearance LESS than 20 mL/min."/>            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="e0b7bb91-f3d1-4c1e-a84c-c2120d78b802" concept_name="PHARM apixaban Tablet Order" max="1" path="/items" name="apixaban tablet; 2.5 mg, oral, once"/>            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="95622e40-f0c5-4230-986a-417f0e26cf42" concept_name="PHARM rivaroxaban Tablet Order" max="1" path="/items" name="rivaroxaban tablet; 10 mg, oral, once"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>          </Item>          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Post Operative Day 1 - Knee Arthroplasty">            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="tinzaparin injection (Extended for 14 days)">              <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="VTE Prophylaxis Patient weight">                <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>                <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin injection; *** units, subcutaneous, every 24 hours, First dose tomorrow at 0800, For 14 days"/>                <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>              </Item>              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>            </Item>            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="95622e40-f0c5-4230-986a-417f0e26cf42" concept_name="PHARM rivaroxaban Tablet Order" max="1" path="/items" name="rivaroxaban tablet; 10 mg, oral, every 24 hours, for 14 days"/>            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="e0b7bb91-f3d1-4c1e-a84c-c2120d78b802" concept_name="PHARM apixaban Tablet Order" max="1" path="/items" name="apixaban tablet; (Consider in patients with higher risk of bleeding); 2.5 mg, oral, every 12 hours, starting tomorrow for 14 days"/>            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f6df7262-0810-4ee2-bb10-c315c36e987c" concept_name="PHARM heparin, preservative free injection Order" max="1" path="/items" name="heparin injection for bolus - units, units/kg/dose; 5,000 units, subcutaneous, every 12 hours, For 14 days"/>            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>          </Item>        </Item>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>      </Item>      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Long-term Anticoagulation Resumption">        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="79608d10-ea50-484c-9e7c-78e4ac1be927" concept_name="PHARM warfarin Tablet Order" max="1" path="/items" name="warfarin tablet; *** mg, oral, once, Day of surgery"/>        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="79608d10-ea50-484c-9e7c-78e4ac1be927" concept_name="PHARM warfarin Tablet Order" max="1" path="/items" name="warfarin tablet; *** mg, oral, once, tomorrow"/>        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="aba3bfd3-dfdb-4f60-baf2-0c1054d1504a" concept_name="PHARM dabigatran Tablet Order" max="1" path="/items" name="dabigatran capsule; 110 mg, oral, every 12 hours"/>        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="aba3bfd3-dfdb-4f60-baf2-0c1054d1504a" concept_name="PHARM dabigatran Tablet Order" max="1" path="/items" name="dabigatran capsule; 150 mg, oral, every 12 hours"/>        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #3"/>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="95622e40-f0c5-4230-986a-417f0e26cf42" concept_name="PHARM rivaroxaban Tablet Order" max="1" path="/items" name="rivaroxaban tablet; 15 mg, oral, every 24 hours"/>        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #4"/>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="95622e40-f0c5-4230-986a-417f0e26cf42" concept_name="PHARM rivaroxaban Tablet Order" max="1" path="/items" name="rivaroxaban tablet; 20 mg, oral, every 24 hours"/>        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #5"/>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="e0b7bb91-f3d1-4c1e-a84c-c2120d78b802" concept_name="PHARM apixaban Tablet Order" max="1" path="/items" name="apixaban tablet; 2.5 mg, oral, every 12 hours"/>        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #6"/>        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="e0b7bb91-f3d1-4c1e-a84c-c2120d78b802" concept_name="PHARM apixaban Tablet Order" max="1" path="/items" name="apixaban tablet; 5 mg, oral, every 12 hours"/>      </Item>      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>    </Item>    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Laboratory Investigations - Repeating">      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d58f0c7d-30da-4d27-a82a-b42c8fae7c23" concept_name="LAB CBC No Differential Order" max="1" path="/items" name="CBC, No Differential; Every 3 days, for 5 occurrences"/>      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ceab0680-290b-4f64-b99f-b4a4451f5e45" concept_name="LAB INR Order" max="1" path="/items" name="INR; Daily Morning, For patients receiving warfarin"/>      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>    </Item>  </definition>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.orderable_section.v1">    <digest id="MD5-CAM-1.0.1">A89AC74BC8CAD3F0719579389C69006F</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.freetextorderquestion.v1">    <digest id="MD5-CAM-1.0.1">5DC6E2FC9E91ADD05E7C5B3E06F83D23</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.booleanorderquestion.v1">    <digest id="MD5-CAM-1.0.1">56B5A2F2979B94F83C97E66B46679692</digest>  </integrity_checks></template>